AI brief of an SEC Form 8-K · Healthcare Services Group (HCSG)

Healthcare Services Group Q4 profit rises to $31.2 million; new $75 million buyback

Positive Impact 4 of 5 earnings Written later

Healthcare Services Group reported fourth-quarter 2025 revenue of $466.7 million, up 6.6%, and net income of $31.2 million, or $0.44 per diluted share, versus $0.16 a year earlier. For the full year, revenue rose 7.1% to $1.84 billion and diluted EPS was $0.81, up from $0.53, and the company expects mid-single-digit revenue growth in 2026. The board also authorized a new buyback of up to 10.0 million shares, with the company planning to repurchase $75.0 million of stock over the next 12 months.

Key points

  • Q4 2025 revenue $466.7 million, up 6.6%; net income $31.2 million, diluted EPS $0.44 versus $0.16 in Q4 2024
  • Full-year 2025 revenue $1.84 billion, up 7.1%; diluted EPS $0.81 versus $0.53 in 2024
  • New buyback authorizes up to 10.0 million shares; company plans to repurchase $75.0 million over the next 12 months
  • 2026 outlook calls for mid-single-digit revenue growth; Q4 cash flow from operations was $17.4 million, or $36.4 million excluding the payroll accrual change

The filing

CompanyHealthcare Services Group (HCSG)
Form8-K, current report
Filed with the SECFeb 11, 2026, 7:01 AM ET
Accession number0000731012-26-000004

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 11, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.